Transforming Hits into High-Value Clinical Leads.
ChemEngine Pharma provides custom medicinal chemistry services, target-focused libraries, and novel hit-to-lead reference compounds. Designed specifically for hit identification, lead optimization, and SAR (Structure-Activity Relationship) studies, our medicinal chemistry portfolio accelerates drug discovery programs across oncology, neuroscience, infectious diseases, and immunology.
Scaffold-focused libraries curated for kinase inhibitors, GPCR modulators, ion channels, and epigenetic targets.
Advanced warheads, functionalized E3 ligase ligands (Cereblon/VHL), and cleavable/non-cleavable linkers for targeted protein degradation.
Systematic analog sets optimized for steric, electronic, and lipophilic modification to refine ADMET profiles.
Benchmark active pharmaceutical ingredients (APIs) and clinical candidates synthesized for in vitro assay validation.
Explore our curated collections by target family and physicochemical rules.
A systematic pipeline driven by our experienced Ph.D. synthetic and medicinal chemists.
Managed by senior Ph.D. synthetic and medicinal chemists.
Rapid turn-around times with highly secure data handling protocols.
Rigorous standards across all stages of analog synthesis.
| Service / Product Line | Synthesis Scale | Purity Standard | Analytical Deliverables |
|---|---|---|---|
| Focused Libraries | Milligram (1–50 mg) | ≥ 90–95% (HPLC) | LC-MS, HPLC, COA, SDF files |
| Lead Optimization Analogs | Multi-mg to Gram | ≥ 95–98% (HPLC) | 1H-NMR, LC-MS, HPLC, COA |
| Degrader (PROTAC) Building Blocks | Gram to Multi-gram | ≥ 95% (HPLC) | 1D/2D-NMR, HRMS, Purity Trace |
| Custom MedChem Synthesis | Tailored to scope | Up to ≥ 99% | Full characterization package (NMR, MS, Chiral HPLC) |
We deliver assay-ready compounds formatted exactly to your screening requirements, backed by uncompromised analytical validation.